Stock Market Reviews

AYTU (Aytu BioPharma, Inc.) News

Get the latest news, insights, and market updates on AYTU (Aytu BioPharma, Inc.). Explore the news page 1 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.

• Aytu BioPharma, Inc.'s (NASDAQ:AYTU) Shift From Loss To Profit
  With the business potentially at an important milestone, we thought we'd take a closer look at Aytu BioPharma, Inc.'s...
  Feb 5, 2026 - $AYTU
• Aytu BioPharma Inc (AYTU) Q2 2026 Earnings Call Highlights: Navigating Challenges and ...
  Aytu BioPharma Inc (AYTU) reports a mixed quarter with decreased revenues but a promising start for its novel depression treatment, EXXUA.
  Feb 4, 2026 - $AYTU
• Aytu BioPharma Reports Fiscal 2026 Second Quarter Operational and Financial Results
  Total net revenue of $15.2 million Adjusted EBITDA1 of $(0.8) million, which includes EXXUA launch investments $30.0 million cash balance at December 31, 2025 Company launched EXXUA™ (gepirone) extended-release tablets ("EXXUA") in December ...
  Feb 3, 2026 - $AYTU
• Aytu BioPharma Inc. (AYTU) Reports Q2 Loss, Beats Revenue Estimates
  Aytu BioPharma (AYTU) delivered earnings and revenue surprises of -303.85% and +26.27%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
  Feb 3, 2026 - $AYTU
• New Strong Sell Stocks for February 2nd
  AAWH, AYTU and BCAL have been added to the Zacks Rank #5 (Strong Sell) List on February 2, 2026.
  Feb 2, 2026 - $AYTU
• Aytu BioPharma to Report Fiscal 2026 Second Quarter Operational and Financial Results on February 3, 2026
  DENVER, CO / ACCESS Newswire / January 27, 2026 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on advancing innovative medicines for complex central nervous system diseases to improve the quality of ...
  Jan 27, 2026 - $AYTU
• Aytu BioPharma Recaps Investor Day Held on January 20, 2026
  DENVER, CO / ACCESS Newswire / January 20, 2026 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on advancing innovative medicines for complex central nervous system diseases to improve the quality of ...
  Jan 20, 2026 - $AYTU
• Aytu BioPharma Highlights Opportunity for EXXUATM (gepirone) as New Way to Treat Major Depressive Disorder That Avoids Common Side Effects of Sexual Dysfunction and Significant Weight Gain following launch of EXXUA
  EXXUA addresses frequent causes of treatment discontinuation with first-line SSRIs and SNRIs Now commercially available through retail pharmacies and participating Aytu RxConnect® pharmacies to support patient access DENVER, COLORADO / ACCESS ...
  Jan 20, 2026 - $AYTU
• Aytu BioPharma to Participate in the Lytham Partners 2026 Investor Healthcare Summit on January 15, 2026
  DENVER, CO / ACCESS Newswire / January 13, 2026 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on advancing innovative medicines for complex central nervous system diseases to improve the quality of ...
  Jan 13, 2026 - $AYTU
• Aytu BioPharma Details Agenda for Investor Day Scheduled for January 20, 2026 in New York City
  DENVER, CO / ACCESS Newswire / January 12, 2026 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on advancing innovative medicines for complex central nervous system diseases to improve the quality of ...
  Jan 12, 2026 - $AYTU